Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(OP: NUMIF )

0.1312 UNCHANGED
Streaming Delayed Price Updated: 3:29 PM EDT, Mar 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.1312
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1312
Today's Range 0.1312 - 0.1312
52wk Range 0.1140 - 0.5105
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Want To Become A Psychedelic-Assisted Therapist? This Company Offers A 'Pathway' Course
Mental healthcare company Numinus Wellness Inc. (OTCQX: NUMIF) is launching a collection of psychedelic-assisted therapist (PAT) training courses for practitioners with multi-modal teaching methods. 
Via Benzinga
In-Clinic Ketamine Businesses Are Shutting Down All Across The US, A Rising Trend?
Closely following the announcement of what's to become of the new regulations for telehealth, including ketamine therapy, several of in-clinic treatment centers have announced they are closing their... 
Via Benzinga

Performance

YTD
-15.08%
-15.08%
1 Month
-17.28%
-17.28%
3 Month
+1.63%
+1.63%
6 Month
-26.08%
-26.08%
1 Year
-67.67%
-67.67%

More News

Read More
EXCLUSIVE: Bienstar Wellness Expands Ibogaine Treatment For Addiction To Curitiba, 3rd Brazilian City Covered By The Co.
Via Benzinga
Psychedelic Stock Gainers And Losers From March 9, 2023
Via Benzinga
Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Via Benzinga
Will Canada Follow Australia And Approve Psychedelic Assisted Therapy? This CEO Believes It Will
Via Benzinga
Psychedelic Stock Gainers And Losers From March 6, 2023
Via Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From March 2, 2023
Via Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From February 28, 2023
Via Benzinga
Psychedelic Stock Gainers And Losers From February 27, 2023
Via Benzinga
Psychedelic Stock Gainers And Losers From February 24, 2023
Via Benzinga
Psychedelic Stock Gainers And Losers From February 23, 2023
Via Benzinga
Psychedelic Stock Gainers And Losers From February 22, 2023
Via Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
Via Benzinga
Psychedelic Stock Gainers And Losers From February 21, 2023
Via Benzinga
Psychedelic Stock Gainers And Losers From February 20, 2023
Via Benzinga
ATAI Life Sciences, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Numinus Debuts 3rd Research Site In US, Touts Faster Services & More Participants
Via Benzinga
Numinus Expands Research Capabilities with new Phoenix Clinical Research Site
Via PressReach
Cybin, Compass Pathways Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From February 15, 2023
Via Benzinga
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
Via Benzinga
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.